Gilead Summits Takeback Of Trodelvy Rights In Deal With Everest

 
• By Alaric DeArment
  
Gilead said it would buy rights to Trodelvy from Everest, which had in-licensed them from Immunomedics in 2019 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business